Bangladesh Pharma Market: 2013

According to the Bangladesh Pharmaceutical Index 2013(1^st Quarter) Total Market size of Bangladesh Pharma Market is Tk 9441 Crore (Local only, except import and export). As usual Sqaure Pharmaceutical Limited leading in front with the 18 % of share of total pharma market, though they are slightly behind from the National Market Growth of 8%. Novo Nordisk has the highest 27% growth in this market with only 8 Generics (Insulin based), UniMed UniHealth has the second highest (20%) and Healthcare Pharma (19%) has the third highest growth in the 1^st Quarter’2013.

Top 20 Brand of Bangladesh Pharma Market: 2011

SI	Brand	Company	Value (Cr)	GRW	Cont% On Total Sale
1	SECLO	Square	134	37	1.67
2	LOSECTIL	SK+F	93	33	1.15
3	PANTONIX	Incepta	72	37	0.90
4	NAPA	Beximco	69	30	0.86
5	NEOTACK	Square	68	25	0.84
6	CEF-3	Square	65	33	0.80
7	NEOCEPTIN R	Beximco	64	-2.4	0.80
8	MAXPRO	Renata	56	66	0.70
9	ZIMAX	Square	54	23	0.67
10	CIPROCIN	Square	53	13	0.66
11	NAPA EXTRA	Beximco	44	44	0.55
12	XELDRIN	ACI	43	18	0.53
13	VOLTALIN	Novartis	40	46	0.50
14	SERGEL	Healtcare	40	56	0.49
15	FUROCEF	Renata	34	35	0.42
16	LEBAC	Square	33	0.7	0.41
17	CEFTRON	Square	32	-4.1	0.40
18	MIXTARD 30	Novo Nor.	32	36	0.39
19	ROLAC	Renata	31	27	0.39
20	OMEP	Aristo	31	43	0.38